CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
allogeneic hematopoietic stem cell transplant (HCT), versus Conventional Care in patients with Active, Relapsed or Refractory Acute Myeloid...
Phase 3
Portland, Oregon, United States and 23 other locations
People with acute myeloid leukemia (AML) are usually treated with chemotherapy. Some people with AML hav...
Phase 1, Phase 2
Portland, Oregon, United States and 19 other locations
\[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse w...
Phase 3
Portland, Oregon, United States and 85 other locations
This study will be conducted in two parts. Part 1 will be the Dose Confirmation portion to determine recommended Phase 3 dose (RPTD) of venetoclax in...
Phase 3
Portland, Oregon, United States and 160 other locations
standard induction chemotherapy in patients with newly diagnosed acute myeloid leukemia. Pemigatinib selectively inhibits ...
Phase 1
Portland, Oregon, United States and 1 other location
to placebo and VEN+AZA alone for the treatment of participants with Acute Myeloid Leukemia (AML) with a mutation ...
Phase 3
Portland, Oregon, United States and 169 other locations
GDX012 is a novel cell therapy developed for the treatment of certain types of cancer, including Acute Myeloid Leukemia (A...
Phase 1, Phase 2
Portland, Oregon, United States and 13 other locations
in subjects with relapsed/refractory B cell malignancies or AML after failure of standard therapies or voruciclib in combination with veneto...
Phase 1
Portland, Oregon, United States and 11 other locations
participants with AML.The duration of this multi-phase study is approximately 7 years....
Phase 2, Phase 3
Portland, Oregon, United States and 71 other locations
This phase I trial studies the side effects of donor natural killer (NK) cell therapy in treating patients with acute myeloid leukemia...
Phase 1
Portland, Oregon, United States and 1 other location
Clinical trials
Research sites
Resources
Legal